What are the pharmacologic treatment options for depression in bipolar disorder type II (BPII)?

Updated: May 30, 2019
  • Author: Stephen Soreff, MD; Chief Editor: Glen L Xiong, MD  more...
  • Print

In the treatment of depression associated with bipolar disorder type II, Swartz and associates reported that 95% of relevant trials were published later than 2005. [95] They noted compelling evidence for the efficacy of quetiapine and preliminary support for the efficacy of lithium, antidepressants, and pramipexole. However, mixed support was noted for lamotrigine. [95]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!